|
🐬
|
Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.
P. Lindholm,
H. Minn,
S. Leskinen-Kallio,
Jörgen Bergman,
Ulla Ruotsalainen,
H. Joensuu
|
8 |
1993 |
8
🐬
|
|
🦁
|
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
H. Minn,
K. Zasadny,
L E Quint,
Richard L. Wahl
|
8 |
1995 |
8
🦁
|
|
🐜
|
F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer
12 auth.
S. Kauhanen,
Gaber Komar,
M. Seppänen,
K. Dean,
H. Minn,
S. Kajander,
...
I. Rinta-Kiikka,
K. Alanen,
R. Borra,
P. Puolakkainen,
P. Nuutila,
J. Ovaska
|
8 |
2009 |
8
🐜
|
|
🐢
|
Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.
16 auth.
T. Otonkoski,
K. Näntö-Salonen,
M. Seppänen,
R. Veijola,
H. Huopio,
K. Hussain,
P. Tapanainen,
O. Eskola,
R. Parkkola,
K. Ekström,
...
Y. Guiot,
J. Rahier,
M. Laakso,
R. Rintala,
P. Nuutila,
H. Minn
|
8 |
2006 |
8
🐢
|
|
🦁
|
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
10 auth.
H. Minn,
M. Lapela,
Pekka J. Klcmi,
R. Grénman,
S. Leskinen,
P. Lindholm,
...
rgen Bergman,
E. Eronen,
M. Haaparanta,
H. Joensuu
|
7 |
1997 |
7
🦁
|
|
🦁
|
Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
H. Minn,
H. Joensuu,
A. Ahonen,
P. Klemi
|
7 |
1988 |
7
🦁
|
|
🐜
|
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
20 auth.
L. Kankaanranta,
T. Seppälä,
H. Koivunoro,
K. Saarilahti,
T. Atula,
J. Collan,
E. Salli,
M. Kortesniemi,
J. Uusi-Simola,
Petteri Välimäki,
...
A. Mäkitie,
M. Seppänen,
H. Minn,
H. Revitzer,
M. Kouri,
P. Kotiluoto,
T. Serén,
I. Auterinen,
S. Savolainen,
H. Joensuu
|
7 |
2012 |
7
🐜
|
|
🐢
|
In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
20 auth.
Esa Kähkönen,
I. Jambor,
J. Kemppainen,
K. Lehtiö,
T. Grönroos,
Anna Kuisma,
P. Luoto,
Henri J. Sipilä,
T. Tolvanen,
K. Alanen,
...
J. Silén,
M. Kallajoki,
A. Roivainen,
N. Schäfer,
R. Schibli,
Martina Dragic,
A. Johayem,
Ray Valencia,
S. Borkowski,
H. Minn
|
7 |
2013 |
7
🐢
|
|
🐢
|
18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer
10 auth.
Gaber Komar,
M. Seppänen,
O. Eskola,
P. Lindholm,
T. Grönroos,
S. Forsback,
...
H. Sipilä,
S. Evans,
O. Solin,
H. Minn
|
7 |
2008 |
7
🐢
|
|
🐢
|
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.
8 auth.
K. Lehtiö,
O. Eskola,
T. Viljanen,
V. Oikonen,
T. Grönroos,
L. Sillanmäki,
...
R. Grénman,
H. Minn
|
7 |
2004 |
7
🐢
|
|
🐜
|
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial
15 auth.
I. Jambor,
Anna Kuisma,
Susan Ramadan,
R. Huovinen,
M. Sandell,
S. Kajander,
J. Kemppainen,
E. Kauppila,
Joakim Auren,
H. Merisaari,
...
J. Saunavaara,
T. Noponen,
H. Minn,
H. Aronen,
M. Seppänen
|
7 |
2016 |
7
🐜
|
